These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 22263524)
21. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies. Esfandiary R; Hayes DB; Parupudi A; Casas-Finet J; Bai S; Samra HS; Shah AU; Sathish HA J Pharm Sci; 2013 Jan; 102(1):62-72. PubMed ID: 23150484 [TBL] [Abstract][Full Text] [Related]
22. Generation of stable cell clones expressing mixtures of human antibodies. de Kruif J; Kramer A; Nijhuis R; van der Zande V; den Blanken R; Clements C; Visser T; Keehnen R; den Hartog M; Throsby M; Logtenberg T Biotechnol Bioeng; 2010 Aug; 106(5):741-50. PubMed ID: 20564612 [TBL] [Abstract][Full Text] [Related]
23. Identifying analytics for high throughput bioprocess development studies. Konstantinidis S; Kong S; Titchener-Hooker N Biotechnol Bioeng; 2013 Jul; 110(7):1924-35. PubMed ID: 23334907 [TBL] [Abstract][Full Text] [Related]
24. Structure-Guided Design of Antibodies. Caravella JA; Wang D; Glaser SM; Lugovskoy A Curr Comput Aided Drug Des; 2010 Apr; ():. PubMed ID: 20402665 [TBL] [Abstract][Full Text] [Related]
25. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
26. Human antibodies from transgenic animals. Lonberg N Nat Biotechnol; 2005 Sep; 23(9):1117-25. PubMed ID: 16151405 [TBL] [Abstract][Full Text] [Related]
27. The challenge of integrating monoclonal antibodies into the current healthcare system. Brixner DI; Bull SA Am J Manag Care; 1997 Jun; 3(6):903-11. PubMed ID: 10170294 [TBL] [Abstract][Full Text] [Related]
28. Formulation and delivery issues for monoclonal antibody therapeutics. Daugherty AL; Mrsny RJ Adv Drug Deliv Rev; 2006 Aug; 58(5-6):686-706. PubMed ID: 16839640 [TBL] [Abstract][Full Text] [Related]
29. Mouse monoclonal antibodies in biological research: strategies for high-throughput production. Chiarella P; Fazio VM Biotechnol Lett; 2008 Aug; 30(8):1303-10. PubMed ID: 18418716 [TBL] [Abstract][Full Text] [Related]
30. Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development. Warne NW Eur J Pharm Biopharm; 2011 Jun; 78(2):208-12. PubMed ID: 21406226 [TBL] [Abstract][Full Text] [Related]
31. Ribosome display: next-generation display technologies for production of antibodies in vitro. He M; Khan F Expert Rev Proteomics; 2005 Jun; 2(3):421-30. PubMed ID: 16000087 [TBL] [Abstract][Full Text] [Related]
36. Moving through three-dimensional phase diagrams of monoclonal antibodies. Rakel N; Baum M; Hubbuch J Biotechnol Prog; 2014; 30(5):1103-13. PubMed ID: 25044865 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal and recombinant antibodies, 30 years after .. Laffly E; Sodoyer R Hum Antibodies; 2005; 14(1-2):33-55. PubMed ID: 16424599 [TBL] [Abstract][Full Text] [Related]
38. A high throughput dimer screening assay for monoclonal antibodies using chemical cross-linking and microchip electrophoresis. Chen X; Flynn GC J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3012-8. PubMed ID: 19646934 [TBL] [Abstract][Full Text] [Related]
39. Biotechnology offers revolution to fish health management. Adams A; Thompson KD Trends Biotechnol; 2006 May; 24(5):201-5. PubMed ID: 16564587 [TBL] [Abstract][Full Text] [Related]